US6046240A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methods for treating female sexual dysfunction
Assignee: RK Co
•
Filing: 1999-04-28
•
Granted: 2000-04-04
•
Expires: 2019-04-28
Abstract
Abstract A method for treating female sexual dysfunction or for female sexual enhancement comprises administering to the vagina a composition comprising a prostanoid compound having a vasodilating effect in a pharmaceutically acceptable vehicle. The amount of prostanoid compound administered ranges from about 0.05 mg to about 3 mg, and preferably from about 0.125 mg to about 1 mg. Preferably the prostanoid compound is prostaglandin E-1 and the pharmaceutically acceptable vehicle is methylcellulose.
Inventors
- 👤 Jackie R. See
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 21:37
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/557; A61K31/5575; A61K31/185; A61K31/19; A61K31/20; A61K9/00; A61K9/0012; A61K9/0034; A61P; A61P15/00; A61K9/10; A61K9/127; A61K9/14; A61K9/19
Claims Analysis
Total Claims: 24
Claim 1
Independent Claim
48 words
A method for treating female sexual dysfunction or for female sexual enhancement comprising administering to the vagina a composition comprising a prostanoid compound having a vasodilating effect in a pharmaceutically acceptable vehicle, wherein the amount of prostanoid compound administered ranges from about 0.05 mg to about 2 mg.
Claim 2
Independent Claim
48 words
A method for treating female sexual dysfunction or for female sexual enhancement comprising administering to the vagina a composition comprising a prostanoid compound having a vasodilating effect in a pharmaceutically acceptable vehicle, wherein the amount of prostanoid compound administered ranges from about 0.05 mg to about 2 mg.
Claim 3
Dependent Claim
22 words
The method according to claim 1, wherein the amount of prostanoid compound administered ranges from about 0.125 mg to about 0.50 mg.
Claim 4
Dependent Claim
22 words
The method according to claim 1, wherein the amount of prostanoid compound administered ranges from about 0.125 mg to about 1 mg.
Claim 5
Dependent Claim
12 words
The method according to claim 1, wherein the prostanoid compound is lyophilized.
Claim 6
Dependent Claim
14 words
The method according to claim 1, wherein the prostanoid compound is encapsulated within liposomes.
Claim 7
Dependent Claim
11 words
The method according to claim 5, wherein the liposomes are lyophilized.
Claim 8
Dependent Claim
13 words
The method according to claim 1, wherein the pharmaceutically acceptable vehicle is methylcellulose.
Claim 9
Dependent Claim
12 words
The method according to claim 1, wherein the composition is administered intravaginally.
Claim 10
Dependent Claim
12 words
The method according to claim 1, wherein the composition is administered extravaginally.
Claim 11
Dependent Claim
13 words
The method according to claim 1, wherein the prostanoid compound is prostaglandin E-1.
Claim 12
Dependent Claim
22 words
The method according to claim 10, wherein the amount of prostanoid compound administered ranges from about 0.125 mg to about 0.50 mg.
Claim 13
Dependent Claim
22 words
The method according to claim 10, wherein the amount of prostanoid compound administered ranges from about 0.125 mg to about 1 mg.
Claim 14
Dependent Claim
14 words
The method according to claim 10, wherein the prostanoid compound is encapsulated within liposomes.
Claim 15
Dependent Claim
11 words
The method according to claim 13, wherein the liposomes are lyophilized.
Claim 16
Dependent Claim
13 words
The method according to claim 10, wherein the pharmaceutically acceptable vehicle is methylcellulose.
Claim 17
Dependent Claim
22 words
The method according to claim 1, wherein the composition further comprises a surfactant capable of enhancing the bioavailability of the prostanoid compound.
Claim 18
Independent Claim
42 words
A method for treating female sexual dysfunction or for female sexual enhancement comprising administering to the vagina a composition comprising lyophilized liposomal prostaglandin E-1 in methylcellulose, wherein the amount of prostaglandin E1 administered ranges from about 0.125 mg to about 1 mg.
Claim 19
Independent Claim
42 words
A method for treating female sexual dysfunction or for female sexual enhancement comprising administering to the vagina a composition comprising lyophilized liposomal prostaglandin E-1 in methylcellulose, wherein the amount of prostaglandin E1 administered ranges from about 0.125 mg to about 1 mg.
Claim 20
Independent Claim
48 words
A method for enhancing blood flow in the vagina of a patient comprising administering to the vagina a composition comprising a prostanoid compound having a vasodilating effect in a pharmaceutically acceptable vehicle, wherein the amount of prostanoid compound administered ranges from about 0.05 mg to about 2 mg.
Claim 21
Independent Claim
48 words
A method for enhancing blood flow in the vagina of a patient comprising administering to the vagina a composition comprising a prostanoid compound having a vasodilating effect in a pharmaceutically acceptable vehicle, wherein the amount of prostanoid compound administered ranges from about 0.05 mg to about 2 mg.
Claim 22
Dependent Claim
22 words
The method according to claim 18, wherein the amount of prostanoid compound administered ranges from about 0.125 mg to about 0.50 mg.
Claim 23
Dependent Claim
22 words
The method according to claim 18, wherein the amount of prostanoid compound administered ranges from about 0.125 mg to about 1 mg.
Claim 24
Dependent Claim
13 words
The method according to claim 18, wherein the prostanoid compound is prostaglandin E-1.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-04-04 | 2003-10-04 | 2004-04-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-04-04 | 2007-10-04 | 2008-04-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-04-04 | 2011-10-04 | 2012-04-04 | $7700.00 | Window Closed / Lapsed |